We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Policy.
Washington — Bipartisan legislation recently introduced in the House would direct OSHA to create employer guidance on acquiring opioid overdose reversal medication and training workers on its use.
Washington — The approval of a second over-the-counter naloxone nasal spray for emergency treatment of a known or suspected opioid overdose is a “game-changer” for its lifesaving potential, the National Safety Council says.
Washington — The opioid epidemic has had a wide-ranging impact on U.S. workers, but employers who support recovery can help, a new policy report states.
Boston — Employees who use illicit substances have increased absenteeism – a “compelling argument” for employers to promote employee treatment programs, results of a recent Boston University study show.
Surrey, British Columbia — For people who are prescribed opioids to treat injury-related pain, experiencing their injury on the job may have a “protective effect” against the risk of future drug overdose.
Itasca, IL — The National Safety Council and Pacira BioSciences Inc., a provider of non-opioid pain management and regenerative health solutions, have announced the Connect2Prevent program, an employee-family educational program intended to increase awareness and prevention of opioid misuse.
Alcohol, cannabis, prescription drugs, fatigue and mental distress can all cause impairment in the workplace. “Impairment risks are everyone’s responsibility,” the National Safety Council says.
Opioid use disorder is defined by Johns Hopkins Medicine as a medical condition in which you’re unable to abstain from using opioids, and behaviors centered around opioid use that interfere with daily life.